NEW YORK and MONTREAL, Aug. 26, 2011 /PRNewswire/ - ICBS Ltd. (OTCPK: ICBT), announced today that partner BioSpec Global Solutions Inc. has opened talks with a U.K. , and Chinese distributors for the TOGS product lines.
“We have opened up negotiations with U.K. and Chinese distributor who are interested in representing the TOGS 3000 and 9000 models for the European and Asian market places” said Don Saunders, President , BioSpec Global Solutions Inc. " We have sent them samples of the TOGS products and expect to sign agreements in the near future.”
The company is currently receiving orders for the TOGS 3000 and 9000 models. BioSpec is also currently working on the completion of the new 9000 model with software and technical upgrades which will allow the 9000 to expand its detection capabilities.
The company has also signed a confidentiality and non-compete agreement with a Chinese manufacturer in Boading China. The Chinese company would manufacture and distribute both the 3000 and 9000 models .
BioSpec Global Solutions Inc., holds worldwide patents on the TOG’s 3000 and 9000 machines for rapid, onsite (remote) monitoring of microbial contamination in drinking water, recreational water, agriculture & food, pharmaceuticals and medical applications.
ICBS specializes in mergers and acquisitions (M&A) advisory services and invests in selective businesses with potential for high growth.
Legal Notice Regarding Forward-Looking Statements:
Safe Harbour: This press release contains forward-looking information within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbour created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of ICBS Limited, to be materially different from the statements made herein.
SOURCE BioSpec Global Solutions Inc.
